BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29073951)

  • 1. Cardiac Effects of Highly Active Antiretroviral Therapy in Perinatally HIV-Infected Children: The CHAART-2 Study.
    Lipshultz SE; Wilkinson JD; Thompson B; Cheng I; Briston DA; Shearer WT; Orav EJ; Westphal JA; Miller TL; Colan SD;
    J Am Coll Cardiol; 2017 Oct; 70(18):2240-2247. PubMed ID: 29073951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study.
    Lipshultz SE; Williams PL; Wilkinson JD; Leister EC; Van Dyke RB; Shearer WT; Rich KC; Hazra R; Kaltman JR; Jacobson DL; Dooley LB; Scott GB; Rabideau N; Colan SD;
    JAMA Pediatr; 2013 Jun; 167(6):520-7. PubMed ID: 23608879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Effects of In Utero Antiretroviral Exposure: Systolic and Diastolic Function in HIV-Exposed Uninfected Youth.
    Guerra V; Leister EC; Williams PL; Starc TJ; Lipshultz SE; Wilkinson JD; Van Dyke RB; Hazra R; Colan SD
    AIDS Res Hum Retroviruses; 2016 Jul; 32(7):621-7. PubMed ID: 26794032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study).
    Lipshultz SE; Shearer WT; Thompson B; Rich KC; Cheng I; Orav EJ; Kumar S; Pignatelli RH; Bezold LI; LaRussa P; Starc TJ; Glickstein JS; O'Brien S; Cooper ER; Wilkinson JD; Miller TL; Colan SD
    J Am Coll Cardiol; 2011 Jan; 57(1):76-85. PubMed ID: 21185505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers.
    Lipshultz SE; Williams PL; Zeldow B; Wilkinson JD; Rich KC; van Dyke RB; Seage GR; Dooley LB; Kaltman JR; Siberry GK; Mofenson LM; Shearer WT; Colan SD;
    AIDS; 2015 Jan; 29(1):91-100. PubMed ID: 25562493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic Follow-up of Perinatally HIV-infected Children and Adolescents: Results From a Single-center Retrospective Cohort Study in Brazil.
    Vallilo NG; Durigon GS; Lianza AC; de Fátima Rodrigues Diniz M; Shiraishi Sawamura KS; Brito CR; de Souza Marques HH; Ferraro AA; Leal GN
    Pediatr Infect Dis J; 2020 Jun; 39(6):526-532. PubMed ID: 32412728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac complications in children with human immunodeficiency virus infection. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group, National Heart, Lung, and Blood Institute.
    Starc TJ; Lipshultz SE; Kaplan S; Easley KA; Bricker JT; Colan SD; Lai WW; Gersony WM; Sopko G; Moodie DS; Schluchter MD
    Pediatrics; 1999 Aug; 104(2):e14. PubMed ID: 10429132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular outcomes of pediatric seroreverters perinatally exposed to HAART: design of a longitudinal clinical study.
    Lavigne JE; Shearer WT; Thompson B; Orav EJ; Starc TJ; Colan SD; Pignatelli R; O'Brien SE; Bezold L; LaRusa P; Easley KA; Cheng I; Duffy SA; Lipshultz SE;
    Cardiovasc Toxicol; 2004; 4(2):187-97. PubMed ID: 15371634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.
    Lipshultz SE; Miller TL; Wilkinson JD; Scott GB; Somarriba G; Cochran TR; Fisher SD
    J Int AIDS Soc; 2013 Jun; 16(1):18597. PubMed ID: 23782480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of HAART on survival, weight gain and resting energy expenditure in HIV-1-infected children in India.
    Banerjee T; Pensi T; Banerjee D; Grover G
    Ann Trop Paediatr; 2010; 30(1):27-37. PubMed ID: 20196931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study.
    Fisher SD; Easley KA; Orav EJ; Colan SD; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; Sopko G; Lipshultz SE;
    Am Heart J; 2005 Sep; 150(3):439-47. PubMed ID: 16169321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
    Gona P; Van Dyke RB; Williams PL; Dankner WM; Chernoff MC; Nachman SA; Seage GR
    JAMA; 2006 Jul; 296(3):292-300. PubMed ID: 16849662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular diastolic dysfunction in HIV-uninfected infants exposed in utero to antiretroviral therapy.
    Lipshultz SE; Sasaki N; Thompson B; Eidem BW; Cheng I; Colan SD; O'Brien SE; Amdani S; Shearer WT; Orav EJ; Miller TL; Wilkinson JD
    AIDS; 2020 Mar; 34(4):529-537. PubMed ID: 31764073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group.
    Lipshultz SE; Easley KA; Orav EJ; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; Sopko G; McIntosh K; Colan SD
    N Engl J Med; 2000 Sep; 343(11):759-66. PubMed ID: 10984563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group.
    Lipshultz SE; Easley KA; Orav EJ; Kaplan S; Starc TJ; Bricker JT; Lai WW; Moodie DS; McIntosh K; Schluchter MD; Colan SD
    Circulation; 1998 Apr; 97(13):1246-56. PubMed ID: 9570194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic Findings in a Cohort of Perinatally HIV-Infected Adolescents Compared with Uninfected Peers from the Cape Town Adolescent Antiretroviral Cohort.
    Mahtab S; Lawrenson J; Jamieson-Luff N; Asafu-Agyei NA; Meiring A; Lemmer-Hunsinger C; Myer L; Zar HJ; Zühlke LJ
    J Am Soc Echocardiogr; 2020 May; 33(5):604-611. PubMed ID: 32147093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins and left ventricular structure and function in pediatric HIV infection.
    Lipshultz SE; Orav EJ; Sanders SP; Colan SD
    Circulation; 1995 Oct; 92(8):2220-5. PubMed ID: 7554205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac function in vertically HIV-infected children and adolescents in the era of highly active antiretroviral therapy.
    Sainz T; Álvarez-Fuente M; Fernández-Jiménez R; González-Tomé MI; de José MI; Ramos JT; Navarro ML; Martínez J; García-Hortelano M; Medrano C; Muñoz-Fernández MÁ; Mellado MJ;
    Pediatr Infect Dis J; 2015 May; 34(5):e125-31. PubMed ID: 25876103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact on weight and height with the use of HAART in HIV-infected children.
    Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
    Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.